The effect of combined exercise and L-arginine on adropine, VEGFR-2 and adhesive molecules in hypertensive postmenopausal wome
Phase 3
- Conditions
- Hypertension.Essential (primary) hypertension
- Registration Number
- IRCT20210627051723N1
- Lead Sponsor
- The University of Tehran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Women 50 to 60 years old with menopause confirmed by a doctor
Confirmation of hypertension
No other cardiovascular diseases
Not participating in regular physical activity in the past year
Exclusion Criteria
Having type 2 diabetes
Restrictions on physical activity
Drug or alcohol addiction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adropin. Timepoint: First, the end of the study. Method of measurement: Kit Elisa.;VEGFR-2. Timepoint: First, the end of the study. Method of measurement: Kit Elisa.;ICAM-1. Timepoint: First, the end of the study. Method of measurement: Kit Elisa.
- Secondary Outcome Measures
Name Time Method Systolic blood pressure. Timepoint: First,the end of the study. Method of measurement: Mercury blood pressure monitor.;Diastolic blood pressure. Timepoint: First,the end of the study. Method of measurement: Mercury blood pressure monitor.